Brooke Boyarsky-Pratt, the CEO of KnownWell, revolutionizes the obesity medicine landscape with her personal journey battling obesity. She discusses the critical role of obesity-specific practitioners and patient-centric medical homes in fostering trust. The conversation delves into the science and impact of GLP-1 medications, highlighting their tailored applications in treatment. The challenges of cost and supply in the obesity sector are addressed, alongside a vision for a more empathetic, comprehensive approach to obesity care.

Brooke Boyarsky Pratt, CEO of knownwell, discusses obesity medicine, patient-centric care, and the future of metabolic health. Topics include GLP-1s for insulin regulation, improving patient access to medications, and the founder's transition from business to healthcare passion.

Brooke Boyarsky Pratt, the founder and CEO of KnownWell, and Jon Jachimowicz, an assistant professor at Harvard Business School, engage in a heartfelt discussion about addressing obesity care. They explore Brooke’s personal battle with weight stigma and her mission to create an inclusive healthcare option. The duo weighs the challenges of scaling her venture against personal passion and the intricacies of navigating career transitions. They also touch on the stigma surrounding obesity in healthcare and the emotional toll of starting a new chapter in one's career.